CONSTANCE

A Study to Determine the Efficacy, Safety, and Durability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration

FaricimabOngoingActive not recruitingPhase 4Open NCT06795048 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…

CONSTANCE · Trial Tracker · ComplyRx